Princess Diana captured on CCTV as she left the Ritz Hotel in Paris shortly before her death in a car crash in 1997.[Reuters] The UK government has finally released a heavily redacted official log detailing the events following the death of Princess Diana in 1997.
SAN DIEGO, April 11, 2017 /PRNewswire/-- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) has approved INGREZZAâ¢ (valbenazine) capsules for the treatment of adults with tardive dyskinesia (TD).
In 2015 an inhaled insulin product, Afrezza, became available in the U.S. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal and can be used by adults with type 1 or type 2 diabetes. Afrezza is not a substitute for long-acting insulin.